The growing burden of chronic diseases, infectious conditions, and expanding healthcare infrastructure worldwide is significantly increasing the demand for blood collection devices. As healthcare systems continue to emphasize early diagnosis, preventive screening, and advanced disease monitoring, blood collection technologies are becoming an essential component of modern medical practice.
According to recent market research, the global Blood Collection Devices Market was valued at USD 8.61 billion in 2024 and reached USD 9.13 billion in 2025. The market is projected to grow at a CAGR of 7.4% from 2025 to 2030, reaching an estimated USD 13.02 billion by 2030.
The market’s growth is fueled by the increasing prevalence of infectious diseases, chronic and lifestyle-related disorders, rising blood donation activities, advancements in diagnostic testing, and the growing adoption of liquid biopsy technologies.
Download the Complete Market Report
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39733117
Market Overview
Blood collection devices are critical tools used for collecting blood samples for diagnostic testing, therapeutic procedures, blood banking, and research applications. These devices help ensure sample integrity, patient safety, and accurate diagnostic outcomes.
Several factors are driving market growth:
- Rising prevalence of diabetes, cardiovascular diseases, cancer, and infectious diseases
- Increasing number of hospitals, clinics, and diagnostic laboratories
- Growing demand for blood donations and blood components
- Expansion of preventive healthcare and routine health screening programs
- Increasing number of trauma and emergency care cases
- Growing adoption of liquid biopsy testing
- Technological advancements in blood collection systems
As healthcare providers focus on faster and more accurate diagnosis, the demand for safe, reliable, and standardized blood collection solutions continues to rise globally.
Blood Collection Tubes Lead the Product Segment
Based on product type, the blood collection devices market is segmented into:
- Blood Collection Tubes
- Needles & Syringes
- Blood Collection Systems/Monitors
- Blood Bags
- Lancets
Among these, the Blood Collection Tubes segment accounted for the largest market share in 2024.
The widespread adoption of blood collection tubes is primarily attributed to their versatility and ability to support multiple diagnostic tests from a single patient sample. These tubes are designed with specialized additives that either promote clot formation or prevent coagulation, making them suitable for a broad range of laboratory applications.
Additional factors supporting segment growth include:
- Increasing laboratory testing volumes
- Standardization of blood collection procedures
- Growing demand for accurate diagnostic results
- Expanding blood banking activities
- Improved sample preservation technologies
Healthcare facilities worldwide continue to rely heavily on blood collection tubes for routine and specialized testing applications.
Diagnostic Applications Dominate the Market
Based on application, the market is divided into:
Diagnostic Applications
Therapeutic Applications
The Diagnostic Applications segment dominated the blood collection devices market in 2024.
This leadership position is driven by the growing demand for blood-based diagnostic testing across healthcare settings. Rising incidences of chronic diseases, increasing preventive health check-ups, and expanding disease screening programs have significantly increased blood sample collection volumes globally.
Key drivers include:
- Rising prevalence of chronic illnesses
- Growth in corporate wellness programs
- Increased focus on preventive healthcare
- Expansion of diagnostic laboratory networks
- Technological advancements in pathology and molecular diagnostics
Furthermore, the integration of automated collection systems and enhanced safety-engineered devices is improving efficiency while reducing contamination risks and needlestick injuries.
Liquid Biopsy Driving New Growth Opportunities
One of the most promising trends shaping the blood collection devices market is the growing adoption of liquid biopsy testing.
Liquid biopsy enables healthcare professionals to detect and monitor diseases such as cancer through blood samples rather than invasive tissue biopsies. These tests require high-quality blood specimens and specialized collection technologies to preserve sample integrity.
Benefits of liquid biopsy include:
- Early disease detection
- Real-time treatment monitoring
- Reduced patient discomfort
- Faster testing procedures
- Improved precision medicine approaches
As personalized healthcare and precision oncology continue to expand, demand for advanced blood collection devices is expected to increase substantially.
North America Maintains Market Leadership
Geographically, the blood collection devices market is segmented into:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
North America accounted for the largest market share in 2024, followed by Europe.
Several factors contribute to the region’s strong position:
Rising Burden of Chronic Diseases
The increasing prevalence of diabetes, cardiovascular diseases, cancer, and blood disorders continues to drive demand for diagnostic testing and blood collection procedures.
Advanced Healthcare Infrastructure
The region benefits from highly developed healthcare systems, sophisticated diagnostic laboratories, and strong blood donation networks.
Presence of Major Industry Players
Many leading blood collection device manufacturers operate extensive research, manufacturing, and distribution facilities throughout North America, contributing to innovation and market expansion.
Growing Focus on Preventive Healthcare
Increasing awareness regarding routine health screening and early disease diagnosis further supports market growth across the region.
Competitive Landscape
The blood collection devices market is highly competitive, with major companies focusing on product innovation, geographic expansion, automation, and strategic partnerships.
Leading market participants include:
- Fresenius Kabi AG (Germany)
- Becton, Dickinson and Company (US)
- Terumo BCT, Inc. (Japan)
- Grifols, S.A. (Spain)
- Cardinal Health (US)
- Nipro Medical Corporation (Japan)
- SARSTEDT AG & Co. KG (Germany)
- Haemonetics Corporation (US)
- Greiner Holding AG (Austria)
- ICU Medical, Inc. (US)
Company Spotlight: Fresenius Kabi AG
Fresenius Kabi AG is a leading player in the global blood collection devices market, particularly in the blood bags segment.
The company has established a strong reputation through:
- Extensive product portfolio
- Reliable global distribution network
- Strong customer relationships
- Continuous product innovation
Fresenius is increasingly investing in automation technologies and sustainable manufacturing practices while expanding its presence across Asia Pacific and Latin America. Growing healthcare infrastructure and blood donation initiatives in these regions present significant opportunities for future growth.
Company Spotlight: Becton, Dickinson and Company (BD)
BD remains one of the most influential companies in the blood collection devices market, offering a comprehensive portfolio that includes:
- Blood collection tubes
- Needles
- Syringes
- Blood bag systems
- Lancets
Its renowned Vacutainer platform continues to be widely used across healthcare facilities worldwide.
In 2023, BD received FDA clearance for an innovative fingerstick blood collection device designed to provide laboratory-quality results at the point of care. Through its BD MiniDraw system, developed in partnership with Babson Diagnostics, the company aims to improve patient access to convenient blood testing services.
BD’s focus on less-invasive sampling methods, digital health integration, and patient-centered innovation continues to strengthen its competitive position.
Company Spotlight: Terumo BCT, Inc.
Terumo BCT is recognized globally for its advanced blood collection and apheresis technologies.
The company continues to strengthen its market position through:
- Investment in automation technologies
- Expansion into emerging markets
- Advanced blood management solutions
- Digital integration platforms
In 2024, Terumo introduced the Intercept 10 Platelet System, an innovative plateletpheresis technology designed to enhance efficiency and safety. The company has also expanded manufacturing operations in the United States and Costa Rica to improve supply chain resilience and meet growing global demand.
Beyond traditional blood collection, Terumo is actively investing in cell therapy and advanced blood management solutions, positioning itself as a technology-driven healthcare leader.
Emerging Trends Shaping the Future
Several important trends are expected to influence the future of the blood collection devices market:
Automation and Smart Collection Systems
Automated collection technologies are improving workflow efficiency and reducing human error.
Patient-Centric Blood Collection
Less-invasive sampling methods and improved patient comfort are becoming key product development priorities.
Growth of Precision Medicine
Increasing use of genomic testing and personalized therapies is driving demand for high-quality blood sample collection.
Expansion of Blood Donation Programs
Government initiatives and awareness campaigns are increasing blood donation rates globally, supporting demand for blood bags and collection systems.
Rising Adoption of Point-of-Care Diagnostics
Portable and rapid testing solutions are creating opportunities for innovative blood collection technologies.
Future Outlook
The blood collection devices market is poised for substantial growth as healthcare providers continue to prioritize early diagnosis, disease monitoring, and patient-centered care. Advances in diagnostic technologies, increasing demand for liquid biopsy testing, and expanding healthcare access across emerging markets are expected to create significant opportunities for manufacturers.
With a projected market value of USD 13.02 billion by 2030, blood collection devices will remain a cornerstone of global healthcare systems, supporting diagnostic accuracy, therapeutic procedures, and lifesaving blood donation programs.
Request Sample Pages
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=39733117
Conclusion
The global Blood Collection Devices Market is witnessing strong momentum driven by rising disease prevalence, expanding diagnostic testing volumes, growing blood donation initiatives, and continuous technological innovation. As healthcare systems increasingly emphasize accurate diagnostics and preventive care, demand for advanced blood collection solutions is expected to accelerate, creating substantial opportunities for manufacturers, healthcare providers, and investors worldwide.
